Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer
Clinical trial NCT07591467 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07591467
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2036-09-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.